Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function.

Rituvanthikaa Seethapathy,Qiyu Wang,Sophia Zhao,Ian A Strohbehn,Joshua D Long,James E Dinulos,Destiny Harden, Vinay B Kadiyala,Daiana Moreno,Meghan E Sise

PloS one（2023）

引用 3|浏览19

暂无评分

摘要

Remdesivir use in patients with impaired kidney function (eGFR between 15 - 60 mL/min/1.73m2) who present to the hospital with COVID-19 is not associated with increased risk of adverse kidney outcomes.

查看译文

关键词

remdesivir,adverse kidney outcomes,impaired kidney function

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要